| Name | Title | Contact Details |
|---|
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
H2O Plus is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. H2O Plus is based in Chicago, IL. You can find more information on H2O Plus at www.h2oplus.com
SpecialtyScripts Pharmacy is a Fall River, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Great HealthWorks is dedicated to providing exceptional, science-based health and wellness products with world class customer service.
California Association Of Hospital and Health is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sacramento, CA. To find more information about California Association Of Hospital and Health, please visit www.calhealth.org